Circ‐PRKDC deficiency decreased β‐catenin and c‐Myc levels in 5‐FU‐resistant CRC cells, implying the inhibition of the Wnt/β‐catenin axis. This evidence concerns the gene PRKDC and colorectal carcinoma.